CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 30 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,622 | -43.8% | 10,470 | -49.3% | 0.00% | – |
| Q1 2023 | $20,668 | +13.8% | 20,670 | -1.3% | 0.00% | – |
| Q4 2022 | $18,167 | +65.2% | 20,935 | +59.7% | 0.00% | – |
| Q2 2022 | $11,000 | -63.3% | 13,110 | +31.1% | 0.00% | – |
| Q1 2022 | $30,000 | -91.0% | 10,000 | -84.7% | 0.00% | – |
| Q4 2021 | $334,000 | – | 65,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,991,003 | $6,990,304 | 0.16% |
| Kynam Capital Management, LP | 739,649 | $739,575 | 0.10% |
| Ikarian Capital, LLC | 219,501 | $219,479 | 0.05% |
| UBS OCONNOR LLC | 574,148 | $574,148 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,027,519 | $1,027,416 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,867 | $26,864 | 0.00% |
| JPMORGAN CHASE & CO | 78,547 | $79,000 | 0.00% |
| Renaissance Technologies | 89,100 | $89 | 0.00% |
| ROYAL BANK OF CANADA | 41 | $0 | 0.00% |
| UBS Group AG | 9,336 | $9,336 | 0.00% |